Theophylline

Quick links to important sections

Theophylline

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Theophylline

Quick Facts

Property Description
Active Ingredient Theophylline (Anhydrous Theophylline)
Form Oral tablets, capsules (usually extended-release); IV solution
Pharmacological Class Methylxanthine derivative; Bronchodilator
Common Purpose Long-term maintenance of breathing conditions
Origin Synthetic drug

What Type of Medication is Theophylline?

Theophylline is a maintenance medication classified as a bronchodilator, primarily used to help manage chronic lung diseases by improving airflow. The active ingredient is the substance itself, formally known as Theophylline (INN), and it belongs to the methylxanthine pharmacological class. This class includes natural compounds like caffeine, but the medication is a synthetic drug manufactured for therapeutic use. The clinical profile of Theophylline has been recognized for its dual action, which includes relaxing smooth muscle and providing mild anti-inflammatory effects. Theophylline is typically prescribed as a prescription-only (Rx) medication due to the requirement for careful monitoring.


What is Theophylline Used For (General Purpose)?

The general purpose of taking Theophylline is to provide continuous, long-term stability and prevention of symptoms for people with chronic breathing conditions. The core function of the drug is to act on the airways, causing the muscles lining the bronchial tubes to relax and open up. This action makes breathing easier and helps to reduce the frequency and severity of breathing difficulties.

Methylxanthines, including Theophylline, exert beneficial effects in patients with chronic respiratory diseases, confirming its long-term stabilizing role. Unlike faster-acting rescue inhalers, Theophylline is uniquely positioned as a sustained therapy designed to maintain open airways over 24 hours.


Forms and Composition: How is Theophylline Packaged?

Theophylline is most commonly packaged as an oral medication in the form of tablets or capsules, usually designed for extended release. These extended-release forms are crucial because they ensure the medicine is released slowly into the bloodstream over many hours, maintaining a steady concentration in the body. The primary route of administration for long-term treatment is oral. It is a single-ingredient drug, typically containing anhydrous Theophylline as the active component. For severe or acute hospital use, a soluble salt form of the drug (often aminophylline) may be given as an intravenous (IV) solution, but this is reserved for critical care settings.

What side effects are possible with Theophylline?

Possible Side Effects and Safety Information

Theophylline's safety profile is characterized by dose-related toxicity, meaning the frequency and severity of adverse reactions are significantly linked to the concentration of the drug in the bloodstream. Effects are generally more pronounced when serum levels exceed the therapeutic range, with serious adverse reactions typically associated with high plasma concentrations.

Regulatory documents classify adverse reactions primarily across three body systems:

  • Nervous System Disorders: Common effects include headache, insomnia (sleeplessness), tremor (fine hand tremor), and restlessness.
  • Gastrointestinal Disorders: Common adverse reactions are nausea, vomiting, and abdominal discomfort.
  • Cardiac Disorders: The label documents effects such as palpitations and tachycardia (rapid heartbeat).

Serious Adverse Reactions and Risk Factors

The most critical adverse events documented in official prescribing information are seizures (convulsions) and severe, life-threatening cardiac arrhythmias. These are usually observed in cases of significantly elevated drug levels.

Safety considerations for specific patient populations are noted in regulatory labels due to altered clearance of the drug:

  • Hepatic Impairment: Patients with liver disease, such as cirrhosis, are at an increased risk of accumulation and toxicity due to significantly reduced clearance.
  • Older Adults: Geriatric patients often require closer monitoring as they may be more susceptible to adverse effects.
  • Co-existing Conditions: The use of Theophylline is generally restricted or cautioned against in patients with active peptic ulcer disease or certain uncontrolled cardiac arrhythmias.

Overdose and Emergency Response

Overdose and When to Seek Help

Theophylline overdose is a potentially serious event, primarily due to the drug’s narrow therapeutic index. Toxicity is commonly associated with serum concentrations exceeding 20 mcg/mL, though risk may be present at lower levels in vulnerable patients.

Documented Overdose Presentations and Risks

Clinical manifestations documented in regulatory sources affect multiple body systems. Gastrointestinal signs include severe or continued vomiting, nausea, and abdominal pain. Cardiovascular effects include rapid heartbeat (tachycardia) and irregular heartbeats (arrhythmias). Central Nervous System effects include tremors, agitation, and convulsions (seizures). Severe, life-threatening outcomes can include cardiac arrest and seizures potentially leading to permanent brain damage.

Seeking Immediate Medical Attention

Regulatory documents mandate that individuals seek immediate emergency medical attention or call the Poison Help line if an overdose is suspected, or if signs of toxicity such as a seizure or severe, continued vomiting occur. Subsequent doses of the medication must be withheld until the serum concentration is measured.

Management and Monitoring

No specific antidote is known for Theophylline overdose. Management involves symptomatic and supportive treatment. Critical requirements include monitoring serum Theophylline concentration, heart rhythm (ECG), and electrolyte balance. Special consideration is noted for high-risk populations, including the elderly, premature neonates, and patients with heart failure or hepatic impairment, who may exhibit toxicity even at therapeutic concentrations.

Therapeutic Uses of Theophylline

What Theophylline Treats: Main Uses and Benefits

Theophylline is a medication used to provide continuous, sustained therapeutic support primarily for patients dealing with chronic respiratory conditions, focusing on improving breathing and overall comfort. Theophylline is considered relevant in clinical settings marked by the need for consistent management of chronic conditions.


The drug is commonly applied in conditions characterized by periods of heightened symptoms, such as Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis, and persistent asthma, relevant when supportive symptom management is appropriate. It is used for managing symptoms that create noticeable physiological strain, such as persistent shortness of breath and wheezing, and is applied during phases when symptoms become more noticeable, such as recurrent chest tightness. In a specialized context, it is also used in the Neonatal Intensive Care Unit (NICU) to manage Apnea of Prematurity in premature infants.

This use provides an additional layer of support that helps ease the overall symptom load and helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for Chronic Airway Symptoms
Primary Focus Long-term support for breathing difficulties linked to chronic airflow obstruction.
Symptom Category Symptoms related to heightened physiological activity, primarily bronchial constriction.
Patient Benefit Helps ease the overall symptom load and assists with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus Drug Information on Theophylline

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Theophylline

Official regulatory documents define specific populations who are restricted or contraindicated for Theophylline use. Absolute contraindication applies to patients with a known hypersensitivity to Theophylline or any other xanthine derivatives.


Classification Official Regulatory Status
Populations for whom use is contraindicated Hypersensitivity to Theophylline or xanthine derivatives.
Populations for whom use is restricted Patients with Hepatic Impairment (e.g., cirrhosis), Congestive Heart Failure (CHF), Cor Pulmonale, Sepsis, or sustained high fever (due to decreased clearance).
Age-related eligibility rules Permitted for Premature Neonates for Apnea of Prematurity; otherwise Infants under six months of age are generally contraindicated. Older adults (ge 60 years) require caution due to potential decreased clearance.
Pregnancy and lactation eligibility Not recommended during pregnancy unless clearly necessary, with a mandatory requirement for monitoring in the third trimester. Excreted into human milk, requiring caution in nursing mothers.

The regulatory structure defines who can and cannot use the medicine by establishing absolute non-eligibility based on hypersensitivity. Conditional eligibility is mandated for patients with compromised physiology (hepatic, cardiac) or acute illness (fever, sepsis) where drug clearance is impaired, increasing the risk of toxicity, according to FDA and EMA labeling.

What should I know about interactions with other medicines?

Theophylline Interactions with other medicines and products

The official regulatory profile for Theophylline identifies several substances that may alter its effects or concentration. Contraindicated combinations include the co-administration of Riociguat and Viloxazine, which are explicitly restricted. Co-use with Fluvoxamine is also generally advised to be avoided.

The majority of documented interactions relate to the drug's metabolism, as Theophylline clearance is affected by medicines that interact with the CYP1A2 enzyme pathway. Substances officially documented to increase Theophylline levels (reduced clearance) include certain antibiotics (e.g., Ciprofloxacin, Erythromycin), Cimetidine, and the asthma medicine Zileuton. Conversely, medications that decrease Theophylline levels (increased clearance) include Rifampicin and the anticonvulsants Phenytoin and Carbamazepine.

In terms of pharmacodynamic effects, Theophylline may inhibit the effect of diagnostic agents like Adenosine, and its concurrent use with Halothane may increase the risk of arrhythmias.

Caution is advised concerning lifestyle products. Tobacco smoking significantly increases clearance, meaning cessation can lead to an increase in Theophylline levels. Use of the herbal product St. John's Wort may decrease Theophylline levels, and high caffeine intake may increase the risk of side effects. Furthermore, official labeling notes that interaction risks are heightened in specific populations, including patients with hepatic impairment, elderly patients, and premature neonates, due to changes in drug handling.

Mechanism of Action

How Theophylline Works

Enzyme Inhibition for Bronchial Smooth Muscle Tone Modulation

Theophylline acts as a weak inhibitor of Phosphodiesterase (PDE) enzymes, primarily the PDE3 and PDE4 isoforms. By blocking PDE, the molecule prevents the breakdown of the second messenger cyclic AMP ( cAMP) inside smooth muscle cells. The resulting increase in cAMP triggers a cascade that reduces muscle tension, leading to the physiological consequence of lowered airway smooth muscle tone.


Restoration of Epigenetic Signaling via HDAC2

This mechanism involves restoring the impaired activity of the enzyme Histone Deacetylase-2 ( HDAC2). HDAC2 is essential for regulating the turning off of pro-inflammatory gene transcription. When its function is restored, the cell can suppress the expression of substances involved in chronic inflammation, which results in a modified expression pattern of inflammatory genes.


Antagonism of Purinergic Receptors

Theophylline acts as a non-selective antagonist of Adenosine receptors. By occupying these receptor sites, the molecule blocks the signaling effect of Adenosine, an endogenous substance that can promote muscle contraction and mediator release. This mechanism results in reduced contractile tone in peripheral smooth muscle and causes generalized CNS excitation through altered neural activity.

Dosage and Administration Information

How to Use Theophylline: Official Administration Guidelines

Theophylline is administered according to standardized protocols to ensure consistent delivery for maintenance therapy. The primary route for long-term use is oral administration, typically via extended-release tablets or capsules. The intravenous (IV) route is reserved for patients requiring acute management or critical care.

Oral administration is most commonly scheduled twice daily (every 12 hours) for extended-release forms, or in some cases once daily, to maintain a constant concentration of the drug. The initial adult oral dose ranges from 300 to 400 mg daily, which is then slowly adjusted, or titrated, based on measured drug levels in the bloodstream. Dose increases must be separated by a minimum of three-day intervals to allow the serum concentration to reach a steady state before further modification.

Procedural Constraints

Standard instructions include specific constraints regarding the physical use and dosing calculation:

Procedural Rule Administration Principle
Tablet Integrity Extended-release forms must be swallowed whole and must not be crushed, broken, or chewed.
Dosing Basis Dose calculations for mg/kg should utilize the patient's ideal body weight.
Population Adjustment Older adults typically require a lower maximum daily dose (e.g., up to 400 mg per day) due to reduced clearance.

All doses should be taken at the same time each day. If a dose is missed, the standard procedure is to take the next scheduled dose at the regular time and not double the dose to compensate.

Recent Clinical Evidence

Research evidence / Overview of Studies for Theophylline

Research on Theophylline for Chronic Obstructive Pulmonary Disease (COPD)

Research has explored Theophylline in studies evaluating long-term outcomes for COPD, a condition marked by functional limitations and conditions involving periods of heightened symptoms. Studies were conducted primarily as short-term Randomized Controlled Trials (RCTs) and observational settings evaluating daily-life functioning in adults and older adults. Researchers monitored functional measures like changes in lung capacity, and also tracked outcomes monitoring physiological strain or stress, such as blood gas levels. When examining clinical outcomes, particularly the overall frequency of exacerbations, findings were mixed across different research settings. Long-term effects are not fully established regarding exacerbation reduction or overall quality of life. Furthermore, evidence quality varies across studies, and many older trials involved smaller populations.

Studies Examining Theophylline for Persistent Asthma

Theophylline was evaluated in research exploring its use in patients with persistent asthma, a condition characterized by fluctuating or episodic manifestations. The evidence landscape primarily includes RCTs that tracked patients whose asthma symptoms were studied while they received initial inhaled therapies. The research explored whether Theophylline, when added to existing treatment, was associated with changes in symptom control and lung capacity measurements. Comparative evidence is lacking against the newest classes of asthma medications, and long-term effects are not fully established. There are concerns related to the narrow therapeutic window required in some studies.

Research on Theophylline for Apnea of Prematurity (AOP)

Theophylline was studied for its use in neonates to manage Apnea of Prematurity. This evidence is primarily derived from controlled RCTs conducted in the NICU setting. Studies monitored the frequency of episodes of stopped breathing and slow heart rate, which are outcomes monitoring physiological strain or stress. The research describes patterns observed in the studies where alterations in the frequency of these physiological events was observed in some studies. Follow-up durations were limited to the short-term treatment period, and data are still emerging for some specific long-term outcomes.

Understanding What is Still Uncertain About Theophylline Research

Several limitations exist in the current body of evidence. Sample sizes were modest in many historical trials, and evidence quality varies across studies, leading to some conflicting findings, especially concerning the reduction of COPD exacerbations. Long-term effects are not fully established for most chronic indications. Furthermore, comparative evidence is lacking against many of the newest available drug classes. Subgroup findings are uncertain for those with high co-morbidity burdens.

Key Studies & References

  1. Theophylline (Anhydrous) Extended Release Tablets, USP Monograph

Frequently Asked Questions (FAQ)

Common questions about Theophylline (FAQ)


Q: How long does it usually take for Theophylline to start working?

Official information describes how the medicine is absorbed based on its form. Oral solutions or immediate-release tablets are generally absorbed rapidly, with the highest concentration in the blood typically occurring within 1 to 2 hours. Intravenous (IV) forms, which are reserved for hospital use, are described as being absorbed within about 30 minutes.


Q: How does Theophylline compare to inhaled medications for breathing problems?

Theophylline is described as a long-acting bronchodilator, which is a type of medicine taken daily for the maintenance and management of chronic breathing symptoms. Official information describes it as a long-acting medicine, not a fast-acting 'reliever' for sudden symptoms, unlike some quick-acting inhaled medications.


Q: Does Theophylline help with long-term breathing management or just flare-ups?

According to official documentation, Theophylline is indicated for the long-term treatment and prevention of symptoms associated with chronic lung diseases. Its purpose is to provide continuous, sustained control. It is not typically used for the rapid relief of acute breathing difficulties or flare-ups.


Q: Can Theophylline cause tremors or shaking?

Yes, regulatory documents list tremor (specifically, fine hand tremor) as a common side effect of Theophylline, which is classified as a Nervous System Disorder. This effect, along with others like restlessness and headache, is generally associated with the concentration of the drug in the bloodstream.


Q: What happens if I miss a dose of Theophylline (informational, non-directive)?

Official guidance instructs taking the next scheduled dose at the regular time and not to double the dose to compensate for the missed one. This instruction is provided because taking extra medication could lead to high and potentially unsafe concentrations of the drug in the bloodstream.


Q: Are there any common beverages that should be avoided while taking Theophylline?

The official product information notes that a high intake of caffeine may increase the risk of side effects like nervousness or rapid heartbeat. For this reason, some patient education materials mention minimizing caffeine intake from sources like coffee, tea, and colas.


Q: What are the described signs of too much Theophylline in the system (descriptive, not clinical advice)?

Signs of high levels in the system, or toxicity, described in regulatory documents include common effects like nausea, vomiting, persistent headache, tremor, and restlessness. Serious adverse effects described include seizures and severe cardiac rhythm changes.


Q: What is the role of blood tests when taking Theophylline?

Blood tests are necessary to measure the precise serum concentration (or level) of Theophylline in the bloodstream. Official guidance requires this because the drug has a narrow therapeutic range, meaning the dose must be carefully controlled to aim for efficacy and prevent dose-related side effects.


Q: Is Theophylline used to treat conditions other than asthma and COPD?

Yes, according to the official indications and usage documents, Theophylline is also prescribed for the management of Apnea of Prematurity (AOP) in premature infants. AOP is a condition where premature babies experience brief periods where they stop breathing.


Q: Do headaches occur frequently with Theophylline use?

Yes, official regulatory documents list headache as a common adverse reaction associated with taking Theophylline. It is often grouped with other nervous system effects like tremor and restlessness.


Q: Is there a link between Theophylline and heart rhythm changes?

Theophylline is officially associated with cardiac side effects. These range from common effects like palpitations and tachycardia (rapid heartbeat) to the risk of severe cardiac arrhythmias. These effects are generally associated with higher drug levels.


Q: What is the typical duration of effect for Theophylline?

The duration of effect depends on the specific formulation being used. The commonly prescribed long-acting (extended-release) forms are specifically designed to maintain a consistent effect for approximately 12 to 24 hours. Short-acting forms, which are less common for maintenance, last around 4 to 6 hours.


Q: Can Theophylline be taken with food, or should it be on an empty stomach?

Taking extended-release tablets or capsules with food can potentially alter the drug levels in the blood. Official advice emphasizes that consistency in administration is important, whether taken consistently with food or consistently on an empty stomach.


Q: What types of interactions are reported between Theophylline and antibiotics?

The most common type of interaction reported between Theophylline and certain antibiotics, such as Erythromycin and Ciprofloxacin, is one where the antibiotics increase the concentration of Theophylline in the body. This is due to the antibiotics affecting how the liver breaks down the medicine, which is reported to raise the risk of side effects.


Q: Can other common medicines for colds or allergies interact with Theophylline?

Official information advises caution when taking Theophylline alongside sympathomimetic agents (common in cold/allergy medicines). Combining them may increase the risk of certain side effects, especially those affecting the heart rate or blood pressure.


Q: Is Theophylline an anti-inflammatory drug?

Theophylline is primarily classified as a bronchodilator because its main function is to relax the airways. However, official information on its mechanism of action notes that it also exhibits mild anti-inflammatory effects at a cellular level.


Q: What patient groups are officially described as needing close monitoring when taking Theophylline?

Official documentation states that patients with conditions that reduce drug clearance, such as hepatic impairment (liver disease), congestive heart failure, or a sustained high fever, are officially noted as populations where close monitoring of Theophylline blood levels may be needed due to reduced clearance. Older adults (age 60 and over) are also noted as a group requiring caution.


Q: What should I know about switching from one Theophylline brand to another?

Official guidance advises generally maintaining the same brand of Theophylline tablets or capsules once treatment is established. The advice relates to potential differences in how the medicine is released and absorbed between brands, which could affect drug levels and require additional monitoring.


Q: Are there any official warnings about driving or operating machinery while taking Theophylline?

Official warnings state that Theophylline may cause side effects like sleepiness or dizziness. Driving or operating complex machinery should be avoided until one is aware of how the medicine may affect them and feel confident it does not impair their ability to perform these tasks.


Q: What is the difference between Theophylline and aminophylline?

Aminophylline is a specific compound that is a salt of Theophylline combined with ethylenediamine. While the active medicine in both is Theophylline, Aminophylline is typically used in the hospital setting for intravenous (IV) administration. Theophylline is the form used for most oral tablets and capsules.


Q: Can Theophylline interact with herbal supplements?

Yes, official documents note interactions with certain herbal products, such as St. John's Wort, which is reported to decrease Theophylline levels in the blood. Patients are generally advised to inform a healthcare provider about all herbal products and supplements being used.


Q: What does the FDA or EMA say about Theophylline's long-term safety?

The FDA has previously determined that Theophylline was not withdrawn from sale for safety or effectiveness reasons. The research overview notes that while the drug has established uses, long-term effects for some chronic indications have not been fully established.


Q: What is the significance of the research evidence for Theophylline?

The body of research evidence confirms Theophylline's role as a drug that can provide long-term management for chronic breathing issues in adults and for Apnea of Prematurity in infants. It helps health professionals understand the drug’s potential as an alternative or additional therapy when initial treatments are insufficient.


Q: How does the drug work to help breathing?

Theophylline works to help breathing primarily by acting as a bronchodilator, a substance that relaxes the smooth muscles surrounding the airways. This action causes the bronchial tubes to open up, which makes it easier to move air in and out of the lungs.


Q: How is the risk of side effects described in official drug information?

The risk of side effects is officially described as being characterized by dose-related toxicity. This means the frequency and severity of adverse reactions are directly linked to the concentration of the drug in the bloodstream. Maintaining levels within the prescribed range is important for managing this risk.

How should Theophylline be stored and disposed of?

Theophylline Storage and Disposal Requirements

Official regulatory guidelines define specific conditions for storing and disposing of Theophylline to maintain its stability and ensure safety.

Storage Conditions

Requirement Regulatory Statement
Temperature Store at controlled room temperature (20 C–25 C / 68 F–77 F). Excursions up to 30 C are permitted.
Protection Protect from light and moisture; avoid excess heat (e.g., do not store in the bathroom).
Packaging Keep in the original container, which must be tightly closed.
Child Safety Keep Theophylline and all medicines out of the reach and sight of children and pets.

Disposal Instructions

Do not flush this medication down the toilet unless explicitly instructed by a healthcare professional or specific labeling. The preferred method for discarding unused or expired Theophylline is by using a medicine take-back program or following the instructions of a pharmacist or local waste disposal company. If a take-back program is unavailable, mix the medicine with an undesirable substance (like coffee grounds or dirt) in a sealed container before disposal in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Theophylline found in:

A-Z Index: